Multistep treatment concept of transsexual patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 6, 1996, Pages 413-419

  Schlatterer, K ^a   Von Werder, K ^b   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cross gender hormone therapy; Sex reassignment surgery; Side effects; Transsexualism

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; ESTROGEN; GESTAGEN; TESTOSTERONE;

ACNE; DEEP VEIN THROMBOSIS; ENDOCRINOLOGY; FEMALE; GALACTORRHEA; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; LIVER DYSFUNCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVIEW; SEX TRANSFORMATION; SIDE EFFECT; THROMBOEMBOLISM; TRANSSEXUALISM; WEIGHT GAIN;

EID: 0030463979     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211479     Document Type: Review

References (63)

1. Asscheman H, Gooren LJG, Assies J, Smits JPH, de Slegte R: Prolactin levels and pituitary enlargement in hormone treated male-to-female transsexuals. Clin Endocrinol 28: 583-588, 1988
2. Asscheman H, Gooren LJG, Eklund PLE: Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism 38: 869-873, 1989
3. Asscheman H, Gooren LJG, Megens JAJ, Kloosterboer HJ, Eikelboom F: Serum testosterone level is the major determinant of the male-female differences in serum levels of high-density lipoprotein (HDL) cholesterol and HDL2 cholesterol. Metabolism 43: 935-939, 1994
4. Baker HJ: Transsexualism - problems in treatment. Am J Psychiatry 125: 1412-1418, 1969
5. Bakker A, van Kesteren PJM, Gooren LJG, Bezemer PD: The prevalence of transsexualism in the Netherlands. Acta Psychiatr Scand 87: 237-238, 1993
6. Bardin CW, Swerdloff RS, Santen RJ: Androgens: Risks and benefits. J Clin Endocrinol Metabol 73: 4-7, 1991
7. Benjamin H: The transsexual phenomenon. New York: Julian Press, 1966
8. Benjamin H: Transvestism and transsexualism. Int J Sexol 7: 12-4, 1953
9. Biller J, Jeffrey LS: Ischemic cerebrovascular disease and hormone therapy for infertility and transsexualism. Neurology 45: 1611-1613, 1995
10. Blumer D: Transsexualism, sexual dysfunction, and temporal lobe disorder. In: Green R, Money J (eds.). Transsexualism and Sex Reassignment. pp. 213-219, John Hopkins Press, Baltimore, 1969
11. Byar DP: The veterans administration cooperative urological research group's studies of cancer of the prostate. Cancer 32: 1126-1130, 1973
12. Clifton KH, Meyer RK: Mechanism of anterior pituitary tumour induction by oestrogens. Anatom Rec. 125: 65-78, 1976
13. Commins D, Yahr P: Autoradiographic localization of estrogen and androgen receptors in the sexually dimorphic area and other regions of the gerbil brain. J Comp Neurol 231: 473-489, 1985
14. Coucil of Europe (1995), Transsexualism, medicine and law, ISBN 92-871-2805-7, Strassbourg, France
15. Damewood MD, Bellantoni JJ, Bachorik PS, Kinball AW Jr, Rock JA: Exogenous estrogen effect on lipid/ lipoprotein cholesterol in transsexual males. J Endocrinol Invest 12: 449-454, 1989
16. de Marinis M, Arnett EN: Cerebrovascular occlusion in a transsexual man taking mestranol. Arch Int Med 138: 1732-1733, 1978
17. de Vries CP, Gooren LJG, van der Veen EA: The effect of cyproterone acetate alone and in combination with ethinylestradiol on the hypothalamic pituitary adrenal axis, prolactin and growth hormone release in male-to-female transsexuals. Horm Metabol Res 18: 203-205, 1986
18. Eklund PLE, Gooren LJG, Bezemer PD: Prevalence of transsexualism in the Netherlands. Br J Psychiatry 152: 638-640, 1988
19. Fortin CL, Klein T, Messmore HL, O'Connell JB: Myocardial infarction and severe thromboembolic complications as seen in an estrogen-dependent transsexual. Arch Int Med 144: 1082-1083, 1984
20. Franks S: Regulation of prolactin secretion by oestrogens: physiological and pathological significance. Clin Sci 65: 457-462, 1983.
21. Ganly I, Taylor W: Breast cancer in a trans-sexual man receiving hormone replacement therapy. Br J Surgery 82: 341, 1995
22. Gesetz über die Änderung der Vornamen und die Feststellung der Geschlechtszugehörigkeit in besonderen Fällen (Transsexuellengesetz - TSG). Bundesgesetzblatt, Jahrgang 1980, Teil I
23. Glashan RW, Robinson MRG: Cardiovascular complications in the treatment of prostatic carcinoma. Br J Urol 53: 624-627, 1981
24. Godlewski J: Transsexualism and anatomic sex: ratio reversal in Poland. Arch Sex Behav 17: 547-548, 1988
25. Goh HH, Loke DFM, Ratnam SS: The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women. Maturitas 21: 65-70, 1995
26. Goodwin WE, Cummings RH: Squamous metaplasia of the verumontanum with obstruction due to hypertrophy: long-term effects of estrogen on the prostate in an aging male-to-female transsexual. J Urol 131: 553-554, 1984
27. Goodwin WE, Scardin PL, Scott WW: A true hermaphrodite. J Urol 71: 748, 1954
28. Gooren L: The endocrinology of transsexualism: review and commentary. Psychoneuroendocrinology 15: 3-14, 1990
29. Gooren LJG, Assies J, Asscheman H, de Slegte R, van Kessel H: Estrogen-induced prolactinoma in a man. J Clin Endocrinol Metab 66: 444-446, 1988
30. Gooren LJG, van der Veen EA, van Kessel H: Modulation of prolactin secretion by gonadal steroids in men. In: MacLeod RM, Scapagnini U (eds.). Central and Peripheral Regulation of Prolactin Function. pp. 373-375, Raven Press, New York, 1980
31. Hannaford PC, Croft PR, Kay CR: Oral contraception and stroke. Stroke 25: 935-942, 1994
32. Jakab RL, Horvath TL, Leranth C, Harada N, Naftolin F: Aromatase immunreactivity in the rat brain: gonadectomy-sensitive hypothalamic neurons and an unresponsive "limbic ring" of the lateral septum-bed nucleus-amygdala complex. J Steroid Biochem Molec Biol 44: 481-498, 1993
33. Khoo SK, Chick P: Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy? Med J Austr 156: 124-132, 1992
34. Kockott G, Fahrner EM: Male-to-female and female-to-male transsexuals: a comparison. Arch Sex Behav 17: 539-546, 1988
35. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS: Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. Arch Pathol Lab Med 118: 562-565, 1994
36. Leavitt F, Berger JC, Hoeppner JA, Northrop G: Presurgical adjustment in male transsexuals with and without hormonal treatment. J Nerv Ment Dis 168: 693-697, 1980
37. Lehrman KL: Pulmonary embolism in a transsexual man taking diethlstilbestrol. JAMA 235: 532-533, 1976
38. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr: Circulating and tissue endothelin immunoreactivity in advanced atheroscleosis. N Engl J Med 325: 997-1101, 1991
39. Lloyd RV: Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland: an immunohistological study. Am J Pathol 113: 198-206, 1983
40. Meyer WJ, Webb A, Stuart CA: Physical and hormonal evaluation of the transsexual patient. A longitudinal study. Arch Sex Behav 15: 121-138, 1986
41. Money J, Gaskin RJ: Sex reassignment. Int J Psychiatry 9: 249-269, 1970
42. Money J, Pollitt E: Cytogenetic and psychosexual ambiguity: Klinefelter's syndrome and transvestism compared. Arch Gen Psychiatr 11: 589-595, 1964
43. Money J, Walker PA: Counseling the transsexual. In: Money J, Musaph H (eds.). Handbook of Sexology. pp. 1289-1301, Elsevier/North Holland Medical Press, 1977
44. Murray-Lyon IB: Hepatotoxicity of certain androgenic steroids. Gender Dysphoria 1: 68-72, 1991
45. Pauly IB, Edgerton MT: The gender identity movement: a growing surgical-psychiatric liaison. Arch Sex Behav 15: 315-329, 1986
46. Peillon F, Bression D, Brandi AM, Racadot J: Pathogenesis of prolactinomas. The role of estrogens and dopamin receptors. In: Lamberts SWJ, Tilder FJH, van der Veen EA, Assies JA (eds.) Trends in diagnosis and treatment of pituitary adenomas. pp. 103, Free University Press, Amsterdam 1984
47. Pérez RL, Machiavelli GA, Romano MI, Burdman JA: Prolactin release, oestrogens and proliferation of prolactin-secreting cells in the anterior pituitary gland of adult male rats. J Endocrinol 108: 399-403, 1986
48. Pfaefflin F, Junge A: Geschlechtsumwandlung, Schattauer, Stuttgart, 1992
49. Polderman KH, Stehouwer CDA, van Kamp GJ, Dekker GA, Verbeugt FWA, Gooren LJG: Influence of sex hormones on plasma endothelin levels. Ann Int Med 118: 429-432, 1993
50. Pritchard TJ, Pankowsky DA, Crowe JP, Abdul-Karim FW: Breast cancer in a male-to-female transsexual. A case report. JAMA 259: 2278-2280, 1988
51. Schlatterer K, Yassouridis A, von Werder K, Poland D, Kemper J, Stalla GK (in press). A pragmatic approach for cross-gender hormone replacement therapy embedded in a multistage treatment concept: follow-up study of 88 transsexual patients. Fertil Steril 1996
52. Sex, hormones, and atherosclerosis (editorial). Lancet 2: 552-553, 1986
53. Sheridan PJ: The nucleus interstitialis striae terminalis and the nucleus amygdaloideus medialis: prime targets for androgen in the rat forebrain. Endocrinol 104: 130-136, 1979
54. Shy KK, McTiernan AM, Daling JR, Weiss NS: Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 249: 2204-2207, 1983
55. Sillero-Arenas M, Delgado-Rodriguez M, Rodrigues-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R: Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 79: 286-294, 1992
56. Sørensen T, Hertoft P: Transsexualism as a nosological unity in men and women. Acta Psychiatr Scand 61: 135-151, 1980
57. Stadel BV:. Oral contraceptives and cardiovascular disease. N Engl J Med 305: 612-618, 672-677, 1981
58. Swaab DF, Hofman MA: Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci 18: 264-270, 1995
59. Symmers WSC: Carcinoma of breast in trans-sexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. Br Med J 2: 83-85, 1968
60. The Coronary Drug Project (Special Communication): Findings leading to the discontinuation of the 2.5 mg/ day estrogen group. JAMA 226: 652-657, 1973
61. Tsoi WF: The prevalence of transsexualism in Singapore. Acta Psychiatr Scand 78: 501-504, 1988
62. Vician L, Shupnik MA, Gorski J: Genetic differences in estrogen-induced deoxyribonucleotide acid synthesis in the rat pituitary: correlation with pituitary tumor susceptibility. Endocrinol 111: 1140-1149, 1982
63. Zhou JN, Hofman MA, Gooren LJG, Swaab DF: A sex difference in the human brain and its relation to transsexuality. Nature 378: 68-70, 1995